# A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects with HPV Positive HNSCC.

> **NCT06797986** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Cellid Co., Ltd.** · enrollment: 37 (estimated)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma (HNSCC)
- HPV (human Papillomavirus)-Associated Carcinoma
- HPV Positive Oropharyngeal Squamous Cell Carcinoma

## Interventions

- **BIOLOGICAL:** BVAC-E6E7 (low level)
- **BIOLOGICAL:** BVAC-E6E7 (high level)
- **BIOLOGICAL:** BVAC-E6E7 (RP2D)

## Key facts

- **NCT ID:** NCT06797986
- **Lead sponsor:** Cellid Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2025-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06797986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06797986, "A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects with HPV Positive HNSCC.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06797986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*